These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 16440350)

  • 1. Use of glucose-responsive material to regulate insulin release from constitutively secreting cells.
    Cheng SY; Constantinidis I; Sambanis A
    Biotechnol Bioeng; 2006 Apr; 93(6):1079-88. PubMed ID: 16440350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hybrid pancreatic tissue substitute consisting of recombinant insulin-secreting cells and glucose-responsive material.
    Cheng SY; Gross J; Sambanis A
    Biotechnol Bioeng; 2004 Sep; 87(7):863-73. PubMed ID: 15334413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a bioartificial pancreas: I. long-term propagation and basal and induced secretion from entrapped betaTC3 cell cultures.
    Papas KK; Long RC; Sambanis A; Constantinidis I
    Biotechnol Bioeng; 1999; 66(4):219-30. PubMed ID: 10578092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering of pseudoislets: effect on insulin secretion activity by cell number, cell population, and microchannel networks.
    Kojima N; Takeuchi S; Sakai Y
    Transplant Proc; 2014 May; 46(4):1161-5. PubMed ID: 24815151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of growth regulation on conditionally-transformed alginate-entrapped insulin secreting cell lines in vitro.
    Simpson NE; Khokhlova N; Oca-Cossio JA; McFarlane SS; Simpson CP; Constantinidis I
    Biomaterials; 2005 Aug; 26(22):4633-41. PubMed ID: 15722133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlling alginate gel degradation utilizing partial oxidation and bimodal molecular weight distribution.
    Boontheekul T; Kong HJ; Mooney DJ
    Biomaterials; 2005 May; 26(15):2455-65. PubMed ID: 15585248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artificial pancreas to treat type 1 diabetes mellitus.
    Calafiore R; Basta G
    Methods Mol Med; 2007; 140():197-236. PubMed ID: 18085211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a bioartificial pancreas: II. Effects of oxygen on long-term entrapped betaTC3 cell cultures.
    Papas KK; Long RC; Sambanis A; Constantinidis I
    Biotechnol Bioeng; 1999; 66(4):231-7. PubMed ID: 10578093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose-induced release of glycosylpoly(ethylene glycol) insulin bound to a soluble conjugate of concanavalin A.
    Liu F; Song SC; Mix D; Baudys M; Kim SW
    Bioconjug Chem; 1997; 8(5):664-72. PubMed ID: 9327129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineering islet for improved performance by optimized reaggregation in alginate gel beads.
    Li N; Sun G; Wang S; Wang Y; Xiu Z; Sun D; Guo X; Zhang Y; Ma X
    Biotechnol Appl Biochem; 2017 May; 64(3):400-405. PubMed ID: 26936645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cryopreservation on cell viability and insulin secretion in a model tissue-engineered pancreatic substitute (TEPS).
    Mukherjee N; Chen Z; Sambanis A; Song Y
    Cell Transplant; 2005; 14(7):449-56. PubMed ID: 16285253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryopreservation effects on recombinant myoblasts encapsulated in adhesive alginate hydrogels.
    Ahmad HF; Sambanis A
    Acta Biomater; 2013 Jun; 9(6):6814-22. PubMed ID: 23499987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin delivery governed by covalently modified lectin-glycogen gels sensitive to glucose.
    Tanna S; Taylor MJ; Adams G
    J Pharm Pharmacol; 1999 Oct; 51(10):1093-8. PubMed ID: 10579679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the fate of dental-derived mesenchymal stem cells using engineered alginate-GelMA hydrogels.
    Ansari S; Sarrion P; Hasani-Sadrabadi MM; Aghaloo T; Wu BM; Moshaverinia A
    J Biomed Mater Res A; 2017 Nov; 105(11):2957-2967. PubMed ID: 28639378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards the development of a bioartificial pancreas: immunoisolation and NMR monitoring of mouse insulinomas.
    Sambanis A; Papas KK; Flanders PC; Long RC; Kang H; Constantinidis I
    Cytotechnology; 1994; 15(1-3):351-63. PubMed ID: 7765950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alginate/polyoxyethylene and alginate/gelatin hydrogels: preparation, characterization, and application in tissue engineering.
    Aroguz AZ; Baysal K; Adiguzel Z; Baysal BM
    Appl Biochem Biotechnol; 2014 May; 173(2):433-48. PubMed ID: 24728760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo bioengineered ovarian tumors based on collagen, matrigel, alginate and agarose hydrogels: a comparative study.
    Zheng L; Hu X; Huang Y; Xu G; Yang J; Li L
    Biomed Mater; 2015 Jan; 10(1):015016. PubMed ID: 25634132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A controlled-release strategy for the generation of cross-linked hydrogel microstructures.
    Franzesi GT; Ni B; Ling Y; Khademhosseini A
    J Am Chem Soc; 2006 Nov; 128(47):15064-5. PubMed ID: 17117838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thromboresistance of glucose-containing hydrogels].
    Valuev IL; Valuev LI; Vanchugova LV; Obydennova IV; Valueva TA
    Prikl Biokhim Mikrobiol; 2013; 49(3):319-21. PubMed ID: 23882951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional examination of microencapsulated bioengineered insulin-secreting beta-cells.
    Hamid M; McCluskey JT; McClenaghan NH; Flatt PR
    Cell Biol Int; 2001; 25(6):553-6. PubMed ID: 11407861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.